Cardiovascular Systems (NASDAQ:CSII) Lifted to “Sell” at BidaskClub
Cardiovascular Systems (NASDAQ:CSII) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Thursday, January 4th.
A number of other equities analysts have also issued reports on CSII. William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a research report on Thursday, December 21st. Needham & Company LLC lowered shares of Cardiovascular Systems from a “buy” rating to a “hold” rating and dropped their target price for the stock from $33.11 to $23.00 in a research report on Friday, December 15th. Raymond James Financial reiterated a “hold” rating on shares of Cardiovascular Systems in a research note on Monday, December 4th. Zacks Investment Research upgraded shares of Cardiovascular Systems from a “sell” rating to a “hold” rating in a research note on Monday, November 13th. Finally, Citigroup started coverage on shares of Cardiovascular Systems in a research note on Thursday, September 21st. They issued a “market perform” rating on the stock. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. Cardiovascular Systems has a consensus rating of “Hold” and a consensus target price of $31.50.
Cardiovascular Systems (CSII) opened at $25.68 on Thursday. Cardiovascular Systems has a 52-week low of $23.00 and a 52-week high of $33.11. The company has a market cap of $880.34, a P/E ratio of 1,290.00 and a beta of 2.53. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.30 and a quick ratio of 3.83.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.